{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:12:25Z","timestamp":1779149545174,"version":"3.51.4"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cca.2019.02.026","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T02:43:33Z","timestamp":1551235413000},"page":"129-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Sickle cell disease: Hemostatic and inflammatory changes, and their interrelation"],"prefix":"10.1016","volume":"493","author":[{"given":"S\u00edlvia L. de O.","family":"Toledo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o V.M.","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia N.","family":"Alpoim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyelle R.A.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina de B.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.02.026_bb0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1100\/tsw.2008.157","article-title":"Sickle cell anemia, the first molecular disease overview of molecular etiology, pathophysiology, and therapeutic approaches","volume":"8","author":"Steinberg","year":"2008","journal-title":"Sci. World J."},{"key":"10.1016\/j.cca.2019.02.026_bb0010","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2019.02.026_bb0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1590\/1516-3180.2013.1314467","article-title":"Clinical and hematological effects of hydroxyurea therapy in sickle cell patients: a single-center experience in Brazil","volume":"131","author":"Pinto","year":"2013","journal-title":"S\u00e3o Paulo Med. J."},{"key":"10.1016\/j.cca.2019.02.026_bb0020","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/03630269.2017.1397017","article-title":"Perinatal maternal mortality in sickle cell anemia: two case reports and review of the literature","volume":"41","author":"Rizk","year":"2017","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cca.2019.02.026_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3233\/CH-189005","article-title":"Blood rheological abnormalities in sickle cell anemia","volume":"68","author":"Connes","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.cca.2019.02.026_bb0035","first-page":"1","article-title":"Changes in hemostasis in sickle cell disease patients","author":"Stypulkowski","year":"2009","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"10.1016\/j.cca.2019.02.026_bb0040","first-page":"358","article-title":"Periapical cytokine expression in sickle cell disease","volume":"41","author":"Ferreira","year":"2015","journal-title":"Basic Res. Biol."},{"key":"10.1016\/j.cca.2019.02.026_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.24986","article-title":"The clinical epidemiology of sickle cell anemia in Africa","volume":"93","author":"Macharia","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2019.02.026_bb0055","first-page":"35","article-title":"Epidemiological profile of patients admitted with sickle cell anaemia in the state of Espirito Santo, Brazil (2001\u22122010)","volume":"18","author":"Sabino","year":"2016","journal-title":"Rev. Bras. Pesq. Sa\u00fade"},{"key":"10.1016\/j.cca.2019.02.026_bb0060","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2019.02.026_bb0065","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0070","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell - endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation"},{"key":"10.1016\/j.cca.2019.02.026_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOH.0000000000000422","article-title":"Clinical manifestations of sickle cell disease in India: misconceptions and reality","volume":"25","author":"Jain","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/JPR.S150065","article-title":"Presence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with sickle cell disease","volume":"11","author":"Bakshi","year":"2018","journal-title":"J. Pain Res."},{"key":"10.1016\/j.cca.2019.02.026_bb0090","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1182\/blood.V128.22.5962.5962","article-title":"Health-related quality of life (HRQL) among hospitalized adults with sickle cell disease (SCD): incorporating patient-reported outcome (PRO) measures in clinical care","volume":"128","author":"Esham","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-018-0930-y","article-title":"Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease","volume":"16","author":"Sarri","year":"2018","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.cca.2019.02.026_bb0100","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ajh.24116","article-title":"2015 clinical trials update in sickle cell anemia","volume":"90","author":"Archer","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0186270","article-title":"The psychosocial impact of leg ulcers in patients with sickle cell disease: I don't want them to know my little secret","volume":"12","author":"Umeh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.02.026_bb0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2143(97)90005-6","article-title":"Platelet activation and aggregates in patients platelet-erythrocyte with sickle cell anemia","volume":"129","author":"Wunt","year":"1997","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0115","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00134-015-4060-2","article-title":"Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study","volume":"41","author":"Maitre","year":"2015","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000362148","article-title":"Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia","volume":"133","author":"Brunetta","year":"2015","journal-title":"Acta Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0125","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hoc.2005.08.002","article-title":"Sickle cell vaso-occlusion","volume":"19","author":"Chiang","year":"2005","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.cca.2019.02.026_bb0130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MOH.0b013e328363442f","article-title":"Hemostatic abnormalities in sickle cell disease","volume":"20","author":"Lim","year":"2013","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/asheducation-2007.1.91","article-title":"Hypercoagulability in sickle cell disease: new approaches to an old problem","author":"Ataga","year":"2007","journal-title":"Am. Soc. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2015.12.003","article-title":"Coagulation abnormalities of sickle cell disease: relationship with clinical outcomes and the effect of disease modifying therapies","volume":"30","author":"Noubouossie","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.cca.2019.02.026_bb0145","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2012.04697.x","article-title":"Pulmonary embolism in sickle cell disease: a case-control study","volume":"10","author":"Novelli","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2006.08.015","article-title":"Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease","volume":"119","author":"Stein","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0155","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology pathophysiology genetics translational medicine and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029786","article-title":"Association of coagulation activation with clinical complications in sickle cell disease","volume":"7","author":"Ataga","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.02.026_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jth.12744","article-title":"Venous thromboembolism incidence in the cooperative study of sickle cell disease","volume":"12","author":"Naik","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.sjbs.2014.09.005","article-title":"Clinical biomarkers in sickle cell disease","volume":"22","author":"Damanhouri","year":"2015","journal-title":"Saudi J. Biol. Sci. Jeddah"},{"key":"10.1016\/j.cca.2019.02.026_bb0175","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood.V84.7.2068.2068","article-title":"Leukocyte-endothelial adhesion molecules","volume":"84","author":"Carlos","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0180","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries new concepts and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.02.026_bb0185","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOH.0b013e3282a4a673","article-title":"Cytokines and plasma factors in sickle cell disease","volume":"14","author":"Brittaina","year":"2007","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1684\/ecn.2013.0328","article-title":"Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition","volume":"24","author":"Keikhaei","year":"2013","journal-title":"Eur. Cytokine Netw Iran"},{"key":"10.1016\/j.cca.2019.02.026_bb0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10739680490278402","article-title":"The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.cca.2019.02.026_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0205","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis associated nitric oxide resistance priapism leg ulceration pulmonary hypertension and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00277-004-0856-9","article-title":"Evidence for a metabolic shift of arginine metabolism in sickle cell disease","volume":"83","author":"Schnog","year":"2004","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism hemolysis associated pulmonary hypertension and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2019.02.026_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.00656","article-title":"Squeezing for life - properties of red blood cell deformability","volume":"9","author":"Huisjes","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cca.2019.02.026_bb0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2008.06.006","article-title":"Function and role of microparticles in various clinical settings","volume":"123","author":"Nomura","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cca.2019.02.026_bb0230","first-page":"75","article-title":"Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases","volume":"60","author":"Meziani","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.cca.2019.02.026_bb0235","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/08916930601061538","article-title":"Microparticles as mediators of cellular cross-talk in inflammatory disease","volume":"39","author":"Distler","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cca.2019.02.026_bb0240","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1160\/TH11-10-0689","article-title":"The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles","volume":"107","author":"Gerotziafas","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11239-013-1028-3","article-title":"Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease","volume":"38","author":"Kasar","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.cca.2019.02.026_bb0250","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3324\/haematol.2012.073619","article-title":"Fetal hemoglobin and hydroxycarbamide modulate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children","volume":"98","author":"N\u00e9bor","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2019.02.026_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3402\/jev.v4.28414","article-title":"Circulating microparticles protein C free protein S and endothelial vascular markers in children with sickle cell anaemia","volume":"4","author":"Piccin","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.cca.2019.02.026_bb0260","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2003-03-0693","article-title":"Sickle blood contains tissue factor positive microparticles derived from endothelial cells and monocytes","volume":"102","author":"Shet","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0265","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2141.2008.07155.x","article-title":"Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability haemolysis and the effects of therapy","volume":"142","author":"Westerman","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2009.09.102","article-title":"Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis","volume":"390","author":"Van Tits","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2019.02.026_bb0275","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/09537104.2012.749397","article-title":"Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications","volume":"24","author":"Tantawy","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.cca.2019.02.026_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177397","article-title":"Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients","volume":"12","author":"Garnier","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.02.026_bb0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","article-title":"Inflammation von Willebrand factor and ADAMTS13","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0290","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","article-title":"D-dimer antigen: current concepts and future prospects","volume":"113","author":"Adam","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0295","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2010-08-302539","article-title":"The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0300","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/S1516-84842010005000043","article-title":"Thrombotic thrombocytopenic purpura: the role of von Willebrand factor and ADAMTS13","volume":"32","author":"Tonaco","year":"2010","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"10.1016\/j.cca.2019.02.026_bb0305","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jth.13728","article-title":"Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state","volume":"15","author":"Sins","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0310","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R","article-title":"Disturbance of plasma and platelet thrombospondin levels in sickle cell disease","volume":"51","author":"Browne","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006627","article-title":"Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2","volume":"2","author":"Lawler","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0320","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2141.2000.02353.x","article-title":"Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia","volume":"111","author":"Inwald","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0325","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.ATV.0000220374.00602.a2","article-title":"Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation","volume":"26","author":"Lee","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.02.026_bb0330","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.106.658641","article-title":"Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease","volume":"115","author":"Raghavachari","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.02.026_bb0335","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","volume":"137","author":"Tomer","year":"2001","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0340","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease hemolysis-associated pulmonary hypertension and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0345","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12308-018-0322-6","article-title":"Study of platelet activation markers and plasma cytokines in sickle cell disease patients during vaso-occlusive pain crises","volume":"11","author":"Osman","year":"2018","journal-title":"J. Hematop."},{"key":"10.1016\/j.cca.2019.02.026_bb0350","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.freeradbiomed.2007.08.014","article-title":"Redox - dependent impairment of vascular function in sickle cell disease","volume":"43","author":"Aslan","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0355","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood-2002-11-3416","article-title":"Phosphatidylserine externalization in sickle red blood cells: associations with cell age density and hemoglobin F","volume":"102","author":"Yasin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0360","first-page":"323","article-title":"Platelet count and platelet factor 3 (PF-3) availability in sickle cell disease","volume":"52","author":"Famodu","year":"1995","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.cca.2019.02.026_bb0365","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/s-0037-1615948","article-title":"Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids","volume":"85","author":"Tomer","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0370","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.thromres.2013.12.008","article-title":"A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation","volume":"133","author":"Jakubowski","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cca.2019.02.026_bb0375","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2141.2010.08087.x","article-title":"Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding diminished cAMP signaling and increased phosphodiesterase 3A activity","volume":"149","author":"Proen\u00e7a-Ferreira","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0380","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood.V98.3.860","article-title":"Characterization of the phosphatidylserine-exposing subpopulation of sickle cells","volume":"98","author":"De Jong","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0385","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/blood.V91.11.4216","article-title":"Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease","volume":"91","author":"Key","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0390","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/CH-189013","article-title":"Hypercoagulable state in sickle cell disease","volume":"68","author":"Faes","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.cca.2019.02.026_bb0395","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2141.2012.09065.x","article-title":"Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of Haemolysis","volume":"157","author":"Setty","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0400","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/MBC.0000000000000494","article-title":"Tissue factor-positive monocytes expression in children with sickle cell disease: clinical implication and relation to inflammatory and coagulation markers","volume":"27","author":"Ragab","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.cca.2019.02.026_bb0405","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2003-10-3719","article-title":"Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia\/reoxygenation and inhibited by lovastatin","volume":"104","author":"Solovey","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0410","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2014.114728","article-title":"Excess of heme induces tissue factor-dependent activation of coagulation in mice","volume":"100","author":"Sparkenbaugh","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2019.02.026_bb0415","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3324\/haematol.11763","article-title":"Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension","volume":"93","author":"Ataga","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2019.02.026_bb0420","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","article-title":"Platelets and thrombin generation","volume":"22","author":"Monroe","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.02.026_bb0425","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.thromres.2012.08.307","article-title":"Characterization of the hypercoagulable state in patients with sickle cell disease","volume":"130","author":"Shah","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cca.2019.02.026_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4084\/mjhid.2011.024","article-title":"Sickle cell disease and venous thromboembolism","volume":"3","author":"Rahimi","year":"2011","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.cca.2019.02.026_bb0435","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/088307389701200103","article-title":"Protein C and protein S activity in sickle cell disease and stroke","volume":"12","author":"Tam","year":"1997","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.cca.2019.02.026_bb0440","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-2143(99)90149-X","article-title":"Antiphospholipid antibodies proteins C and S and coagulation changes in sickle cell disease","volume":"134","author":"Westerman","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0445","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0450","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajh.22206","article-title":"Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children","volume":"87","author":"Noubouossie","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2006.11.004","article-title":"Coagulation 2006: a modern view of hemostasis","volume":"21","author":"Hoffman","year":"2007","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.cca.2019.02.026_bb0460","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.hoc.2013.11.011","article-title":"Role of the hemostatic system on SCD pathophysiology and potential therapeutics","volume":"28","author":"Pakbaz","year":"2014","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.cca.2019.02.026_bb0465","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jth.13957","article-title":"Measuring fibrinolysis: from research to routine diagnostic assays","volume":"16","author":"Longstaff","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0470","doi-asserted-by":"crossref","first-page":"16713","DOI":"10.1074\/jbc.M110.101691","article-title":"Placenta growth factor (PlGF) a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD)","volume":"285","author":"Patel","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.026_bb0475","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0902-4441.2003.00209.x","article-title":"Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report","volume":"72","author":"Ahmed","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0480","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00282-996-0279-2","article-title":"Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease","volume":"38","author":"Nsiri","year":"1996","journal-title":"Hematol. Cell Ther."},{"key":"10.1016\/j.cca.2019.02.026_bb0485","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00001721-199504000-00001","article-title":"Changes in coagulation and fibrinolysis in patients with sickle-cell disease compared with healthy black controls","volume":"6","author":"Hagger","year":"1995","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.cca.2019.02.026_bb0490","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00282-997-0229-7","article-title":"Fibrinolytic response to venous occlusion in patients with homozygous sickle cell disease","volume":"39","author":"Nsiri","year":"1997","journal-title":"Hematol. Cell Ther."},{"key":"10.1016\/j.cca.2019.02.026_bb0495","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood-2016-01-694422","article-title":"Elevated D-dimer levels in African Americans with sickle cell trait","volume":"127","author":"Naik","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0500","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1076029611420992","article-title":"Biomarkers of inflammation growth factor and coagulation activation in patients with sickle cell disease","volume":"18","author":"Qari","year":"2012","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0505","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0510","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.trsl.2015.07.001","article-title":"Inflammatory targets of therapy in sickle cell disease","volume":"167","author":"Ansah","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.cca.2019.02.026_bb0515","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cyto.2013.10.009","article-title":"Chronic inflammatory state in sickle cell anemia patients is associated with HBB*S haplotype","volume":"65","author":"Bandeira","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2019.02.026_bb0520","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2141.2009.08013.x","article-title":"Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises","volume":"148","author":"Krishnan","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0525","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2013-10-529982","article-title":"Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0530","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3324\/haematol.2013.088021","article-title":"Nucleosomes and neutrophil activation in sickle cell disease painful crisis","volume":"98","author":"Schimmel","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2019.02.026_bb0535","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/03630260600642260","article-title":"Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome","volume":"30","author":"Ballas","year":"2006","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cca.2019.02.026_bb0540","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1542\/peds.2004-2107","article-title":"Serum biomarkers for identifying acute chest syndrome among patients who have sickle cell disease and present to the emergency department","volume":"116","author":"Naprawa","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.cca.2019.02.026_bb0545","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2141.2006.06409.x","article-title":"Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2","volume":"136","author":"Styles","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0550","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2009-09-244830","article-title":"High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension","volume":"116","author":"Sundaram","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0555","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ajh.21370","article-title":"Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease","volume":"84","author":"Field","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0560","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","article-title":"Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion","volume":"96","author":"Belcher","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0565","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2002-11-3422","article-title":"Placenta growth factor activates monocytes and correlates with sickle cell disease severity","volume":"102","author":"Perelman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0570","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.1439808","article-title":"Selectins: interpreters of cell-specific carbohydrate information during inflammation","volume":"258","author":"Lasky","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.cca.2019.02.026_bb0575","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1182\/blood.V98.2.458","article-title":"Intercellular adhesion molecule-4 binds alpha(4)beta(1) and alpha(V)-family integrins through novel integrin-binding mechanisms","volume":"98","author":"Spring","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0580","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V85.1.268.bloodjournal851268","article-title":"Sickle reticulocytes adhere to VCAM-1","volume":"85","author":"Gee","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0585","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood.V92.10.3924","article-title":"Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes","volume":"92","author":"Sultana","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0590","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils platelets and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0595","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcmd.2016.10.020","article-title":"Inflammatory and oxidative stress phenotypes in transgenic sickle cell mice","volume":"62","author":"Charrin","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cca.2019.02.026_bb0600","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"92","author":"Frenette","year":"2002","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0605","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.exphem.2016.03.008","article-title":"Cytokine polymorphisms in sickle cell disease and the relationship with cytokine expression","volume":"44","author":"Gilli","year":"2016","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0610","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2014.11.030","article-title":"Serum IL-6 IL-10 and TNF\u03b1 levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition","volume":"72","author":"Sarray","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2019.02.026_bb0615","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cyto.2017.03.010","article-title":"Relationship between serum 25-hydroxyvitamin D and inflammatory cytokines in pediatric sickle cell disease","volume":"96","author":"Adegokea","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2019.02.026_bb0620","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000204452","article-title":"Level of tumor necrosis factor alpha\/cachectin (TNF alpha) in sera from patients with sickle cell disease","volume":"90","author":"Malav\u00e9","year":"1993","journal-title":"Acta Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0625","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/01.RES.0000243989.46006.b9","article-title":"Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis","volume":"99","author":"Ahmad","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2019.02.026_bb0630","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0167-5699(94)90137-6","article-title":"The acute phase response","volume":"15","author":"Baumann","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cca.2019.02.026_bb0635","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.20196","article-title":"Cytokine profile of sickle cell disease in Oman","volume":"77","author":"Pathare","year":"2004","journal-title":"Am. J. Hematol. Sultanate Oman"},{"key":"10.1016\/j.cca.2019.02.026_bb0640","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2019.02.026_bb0645","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002770000173","article-title":"The role of cytokines in sickle cell disease","volume":"79","author":"Makis","year":"2000","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0650","first-page":"1","article-title":"Neutrophil extracellular Traps and its implications in inflammation: an overview","volume":"8","author":"Rizo","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2019.02.026_bb0655","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrmicro1710","article-title":"Beneficial suicide: why neutrophils die to make NETs","volume":"5","author":"Brinkmann","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cca.2019.02.026_bb0660","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cca.2019.02.026_bb0665","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.hoc.2013.11.006","article-title":"Inflammatory mediators of endothelial injury in sickle cell disease","volume":"28","author":"Hopp","year":"2014","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.cca.2019.02.026_bb0670","first-page":"148","article-title":"Influence of storage time and amount of red blood cell transfusion on postoperative renal function: an observational cohort study","volume":"5","author":"Schimmer","year":"2013","journal-title":"Heart Lung Vessel"},{"key":"10.1016\/j.cca.2019.02.026_bb0675","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.ai.2016.05.001","article-title":"The roles of the secreted phospholipase A2 gene family in immunology","volume":"132","author":"Murakami","year":"2016","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.cca.2019.02.026_bb0680","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/blood.V96.9.3276","article-title":"Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease","volume":"96","author":"Styles","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0685","first-page":"61","article-title":"Placenta growth factor mediated gene regulation in sickle cell disease","volume":"32","author":"Kalra","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0690","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/blood-2009-04-217950","article-title":"Placenta growth factor in sickle cell disease: association with hemolysis and inflammation","volume":"115","author":"Brittain","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0695","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2002-11-3423","article-title":"Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor","volume":"102","author":"Selvaraj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0700","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Golden","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0705","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-20","article-title":"Measurement of leukotrienes in humans","volume":"161","author":"Kumlin","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0710","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0140-6736(93)91073-U","article-title":"Leukotriene E4 and granulocyticinfiltration into asthmatic airways","volume":"34","author":"Laitinen","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2019.02.026_bb0715","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1164\/ajrccm.158.supplement_2.13tac180","article-title":"Leukotrienes as mediators of airway obstruction","volume":"158","author":"Drazen","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0720","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1161\/01.CIR.92.11.3304","article-title":"Peptido-leukotrienes are potentagonists of von Willebrand factor secretion and P-selectin surface expressionin human umbilical vein endothelial cells","volume":"92","author":"Datta","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.02.026_bb0725","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2257.2002.t01-1-00433.x","article-title":"Activated monocytes and plateletmonocyte aggregates in patients with sickle cell disease","volume":"24","author":"Wun","year":"2002","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0730","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00109-013-1074-5","article-title":"Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis cancer and beyond","volume":"91","author":"Danckwardt","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-3-25","article-title":"Ovarian cancer the coagulation pathway and inflammation","volume":"3","author":"Wang","year":"2005","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0740","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2011-11-391532","article-title":"Asthma and coagulation","volume":"119","author":"Boer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0745","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMcibr1311045","article-title":"Asthma and coagulation","volume":"369","author":"Lambrecht","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0750","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2010.09.030","article-title":"Pre-eclampsia: relationship between coagulation fibrinolysis and inflammation","volume":"412","author":"Dusse","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.02.026_bb0755","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(11)70012-3","article-title":"Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation","volume":"127","author":"Girardi","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cca.2019.02.026_bb0760","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1160\/THS10-11-0739","article-title":"Inflammation and thrombosis in diabetes","volume":"105","author":"Hess","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0765","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1309\/LMF8R2KSTOW3FLKD","article-title":"Associations between inflammatory markers hemostatic markers and microvascular complications in 182 Chinese patients with type 2 diabetes mellitus","volume":"46","author":"Zheng","year":"2015","journal-title":"Lab. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0770","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1160\/TH07-08-0483","article-title":"Crosstalk between coagulation and inflammation during Dengue virus infection","volume":"99","author":"Huerta-Zepeda","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc4975","article-title":"Coagulation abnormalities in critically ill patients","volume":"10","author":"Levi","year":"2006","journal-title":"Crit. Care"},{"key":"10.1016\/j.cca.2019.02.026_bb0780","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-0037-1617143","article-title":"The coagulant response in sepsis and inflammation","volume":"30","author":"Levi","year":"2010","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.cca.2019.02.026_bb0785","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tcm.2005.07.004","article-title":"Two-way interactions between inflammation and coagulation","volume":"15","author":"Levi","year":"2005","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0790","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cca.2019.02.026_bb0795","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/bjh.12300","article-title":"Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia","volume":"161","author":"Connes","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2019.02.026_bb0800","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-04-424143","article-title":"Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease","volume":"120","author":"Chantrathammachart","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0805","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2013-08-523936","article-title":"Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease","volume":"123","author":"Sparkenbaugh","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-3-50","article-title":"Health related quality of life in sickle cell patients: the PiSCES project","volume":"3","author":"Mcclish","year":"2005","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.cca.2019.02.026_bb0815","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0140-6736(03)14689-2","article-title":"Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology","volume":"362","author":"Setty","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.cca.2019.02.026_bb0820","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/blood.V98.12.3228","article-title":"Thrombophilia in sickle cell disease: the red cell connection","volume":"98","author":"Setty","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.026_bb0825","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/jth.13416","article-title":"Thrombin generation and cell-dependent hypercoagulability in sickle cell disease","volume":"14","author":"Whelihan","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.02.026_bb0830","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.freeradbiomed.2003.11.032","article-title":"The biochemistry of nitric oxide nitrite and hemoglobin: role in blood flow regulation","volume":"36","author":"Gladwin","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2019.02.026_bb0835","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.biocel.2006.01.010","article-title":"Sickle cell disease and nitric oxide: a paradigm shift?","volume":"38","author":"Mack","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cca.2019.02.026_bb0840","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.3324\/haematol.12632","article-title":"No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension","volume":"93","author":"Van Beers","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2019.02.026_bb0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4084\/mjhid.2018.017","article-title":"Adult sickle cell anaemia patients in bone pain crisis have elevated proinflammatory cytokines","volume":"10","author":"Alagbe","year":"2018","journal-title":"Mediterr J. Hematol. Infect Dis."},{"key":"10.1016\/j.cca.2019.02.026_bb0850","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/153537020523000109","article-title":"Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease","volume":"230","author":"Hibbert","year":"2005","journal-title":"Exp. Biol. Med. (Maywood)"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119300889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119300889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:49:14Z","timestamp":1757861354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119300889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":170,"alternative-id":["S0009898119300889"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.02.026","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sickle cell disease: Hemostatic and inflammatory changes, and their interrelation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}